Blu Label Unlimited Group (BLU) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
27 Aug, 2026Executive summary
Strategy is built on eight pillars: technology, product, distribution, energy, treasury/procurement, special projects, postpaid, and Cell C, with a CAPEX-light model and focus on proprietary platforms and data analytics for innovation.
Product innovation includes Blu Voucher, Ringas, UniPIN, Blu Advance, and Ticketpro, with strong Blu Voucher sales and new emergency electricity top-up products.
Distribution spans formal, informal, banking, and petroleum sectors, with the Blue Train Group initiative for employment and training.
Energy segment (Cigicell/BluEnergy) expands from token vending to revenue assurance and green energy production for municipalities.
Brand and MVNO business showed notable momentum, with recognition for best video experience in South Africa.
Financial highlights
Effective revenue for the half year rose 8% year-over-year to R47.4 billion (reported revenue R7.2 billion due to PINless accounting).
Gross profit increased 2% to R1.63 billion, with gross margin up to 22.44%.
Core headline earnings per share up 0.4% to 47.20 cents.
EBITDA decreased 6% to R653 million, mainly due to lower CEC subscriber base and higher finance costs.
Net profit after tax was R395 million; capital and reserves at R5.5 billion.
Outlook and guidance
Management expects continued growth in gross revenue from universal vouchers and prepaid electricity, supported by NERSA-approved tariff adjustments and increased consumption.
Focus on executing strategic priorities, integrating postpaid business, investing in digital platforms, and accelerating MVNO and B2B growth.
No further Blu Label cash injections into Cell C anticipated; Cell C is self-sustaining.
Dividend payments may resume in 2024, pending board approval.
Consolidation of Cell C into Blu Label group delayed until after May 2025, pending regulatory approval.
Latest events from Blu Label Unlimited Group
- AGM approved key resolutions, addressed diversity, ESG, and Cell C governance, with most motions passed.BLU
AGM 2024 - Significant declines in earnings expected due to Cell C restructuring and listing impacts.BLU
Trading update - Normalized revenue ZAR 9.4bn, EBITDA ZAR 923m, core headline earnings ZAR 681m, dividend and buyback.BLU
H2 2026 - Earnings per share are expected to rise over 100%, but underlying earnings fell when excluding Cell C effects.BLU
Trading update - Earnings per share are expected to rise by over 20% for the year ended 31 May 2025.BLU
Trading update - Earnings per share to fall over 20%, impacted by Cell C restructuring and related losses.BLU
Trading update - Gross revenue up 16% to ZAR 89.3bn, but core HEPS down 34% amid challenging conditions.BLU
H2 2024 - Profit and margin growth accelerated, led by digital innovation and Cell C's operational turnaround.BLU
H2 2025 - Cell C restructuring and 11% revenue growth enabled dividend resumption and strong cash flow.BLU
H1 2026